SITC 2026 has ended. This guide stays up as the record of who was there. Next: SITC 2027, Nov 3–7, 2027 in National Harbor
AC
The Angeles Clinic and Research Institute at SITC 2026
Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website
The Angeles Clinic and Research Institute brings 3 presentations to SITC 2026 in Phoenix. Its program centres on bispecific drugs that block VEGF and the PD-1 pathway at once, set within a debate over whether the approach lives up to its promise. It also reports early results for brenetafusp, alone or with tebentafusp, in metastatic uveal melanoma.
| Organization | SITC 2026 Attendance |
|---|---|
AC The Angeles Clinic and Research Institute Los Angeles, CA | |
Oncology practice and clinical research institute in Los Angeles, affiliated with Cedars-Sinai. | Session Fri Nov 6 11:45am–12:15pm Clinical Oral Abstract Session
Talk Sat Nov 7 2:00pm–2:15pm Talk Sun Nov 8 8:10am–8:15am Session Sun Nov 8 10:45am–12:25pm COOPERATIVE BINDING: The bi-specific VEGF/PD(L)-1 Inhibitor Approach to cancer immunotherapy: Savior or Pretender?
Talk Sun Nov 8 11:45am–12:00pm |
Find decision makers at The Angeles Clinic and Research Institute
Tell us what you sell and we’ll find the people at The Angeles Clinic and Research Institute most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction